News Image

Ocugen To Present at BIO International Convention 2025

Provided By GlobeNewswire

Last update: Jun 11, 2025

MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present at the 2025 BIO International Convention at the Boston Convention & Exhibition Center from June 16-19, 2025.

Read more at globenewswire.com

OCUGEN INC

NASDAQ:OCGN (7/23/2025, 7:52:08 PM)

After market: 1.17 0 (0%)

1.17

+0.14 (+13.59%)



Find more stocks in the Stock Screener

Follow ChartMill for more